These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Similarity and differences of the effect of epsilon-aminocaproic acid on allergic-hyperergic reactions and degenerative forms of rheumatism, especially on arthrosis deformans]. Oswald W Dtsch Gesundheitsw; 1968 Jan; 23(2):59-61. PubMed ID: 5680688 [No Abstract] [Full Text] [Related]
6. [The use of epsilon-aminocaproic acid in the treatment of acute pancreatits]. Karavanov AG; Osingolts SL Klin Med (Mosk); 1966 May; 44(5):13-5. PubMed ID: 4865586 [No Abstract] [Full Text] [Related]
7. [Therapy of lumbara arthrosis and coxarthrosis with a recently synthetized molecule with antirheumatic action]. Cazzagon R; Mattara L; Leardini G Minerva Med; 1973; 64(48):2665-7. PubMed ID: 4580160 [No Abstract] [Full Text] [Related]
8. [Use of epsilon-aminocaproic acid in the therapy of parodontosis]. Belikov PP Stomatologiia (Mosk); 1977; 56(4):81-2. PubMed ID: 329485 [No Abstract] [Full Text] [Related]
9. [The administration of epsilon-aminocaproic acid in hemophelia]. van Creveld S; de Vos-Bongaardt CM Maandschr Kindergeneeskd; 1966 Sep; 34(9):285-9. PubMed ID: 5341361 [No Abstract] [Full Text] [Related]
10. The use of epsilon aminocaproic acid as an adjunct to replacement therapy in hemophiliacs undergoing tooth extraction. (Part I). Evans BE N Y J Dent; 1981 Mar; 51(3):83-90. PubMed ID: 7010243 [No Abstract] [Full Text] [Related]
11. [The treatment of severe coxarthrosis with Ketoprofen (author's transl)]. Frank O; Klemmayer K Schweiz Rundsch Med Prax; 1974 Aug; 63(33):1003-4. PubMed ID: 4603904 [No Abstract] [Full Text] [Related]
12. [Therapeutic trial with epsilon-aminocaproic acid in psoriasis vulgaris]. Rowe E; Meffert H; Wischnewsky GG; Buchholz W Dermatol Monatsschr; 1985; 171(4):230-2. PubMed ID: 3891434 [No Abstract] [Full Text] [Related]
13. [Comparative study: Alclofenac vs Indomethacin in the treatment of coxarthrosis]. Fellmann N Schweiz Rundsch Med Prax; 1971 Jun; 60(26):882-4. PubMed ID: 4933495 [No Abstract] [Full Text] [Related]
14. Cardiac and renal hemodynamic effects of the antifibrinolytic agent, epsilon aminocaproic acid. Swartz C; Onesti G; Ramirez O; Shah N; Brest AN Curr Ther Res Clin Exp; 1966 Jul; 8(7):336-42. PubMed ID: 4957166 [No Abstract] [Full Text] [Related]
15. [Antihemorrhagic agent of choice in pediatric ENT: capramol Choay (epsilon-aminocaproic acid)]. Berger M; Pinson J Med Bord; 1965 Apr; 142(4):719-21. PubMed ID: 5318696 [No Abstract] [Full Text] [Related]
16. Intra-arterial use of No-Spa+lidocaine in coxarthrosis. Tantó Z; Molnár L; Kálózdi T; Maros M; Várhelyi M Ther Hung; 1982; 30(3):134-6. PubMed ID: 6765332 [No Abstract] [Full Text] [Related]
17. Fibrinolytic activity in hemophilia and the use of epsilon-aminocaproic acid. Ritz ND N Y State J Med; 1965 Dec; 65(23):2914-25. PubMed ID: 5320118 [No Abstract] [Full Text] [Related]
18. [3,4,5-trimethoxylbenzoyl-epsilon-amino.....aminocaproic acid in acute myocardial infarction. (author's transl)]. Masini V; Floris B; Santini M G Ital Cardiol; 1974; 4(6):770-2. PubMed ID: 4448349 [No Abstract] [Full Text] [Related]